Scarica l'app Stockscreener
10.87
0.09%
0.010
Drugs Made In America Acquisition Corp Borsa (DMAA) Ultime notizie
DMII 8-K & SEC Filings - Yahoo Finance Australia
DMAA Stock Holds Near $10.89 as Acquisition Corp. Trades in Tight BandOutside Reversal - https://www.dars.gov.et/
DMIIU Holds Steady at $10.20 as Drugs Made In America Acquisition II Unit Trades FlatBreakout Stock Alerts - https://www.dars.gov.et/
HVMC Stock Price, Quote & News - Syfe
Drugs Made In America Restructures Merger with PAGC - The Globe and Mail
DMAA resets Power Analytics merger at $2.85B fixed valuation - Dealroom
Inside the $2.85B all-stock deal for DMAA (NASDAQ: DMAA) - Stock Titan
DMII 8-K & SEC Filings - Yahoo Finance Australia
EVOX Stock Price, Quote & News - Syfe
Starton Therapeutics Appoints Experienced Finance Executive Saleem Elmasri, CPA, as Chief Financial Officer - The Manila Times
DMAAR Rights Rise 8.43% to $0.13 on Renewed Interest in Drugs Made In America SPACGap Down Bounce Plays - dars.gov.et
DMAAR Rights Rise 8.43% to $0.13 on Renewed Interest in Drugs Made In America SPACFund Manager Survey - dars.gov.et
Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within RangeValue Area Low - dars.gov.et
Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within RangeQuality ETF - careplusvn.com
Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0%Should You Sell? - MarketBeat
Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingBuy Signal Reports - vinanet.vn
Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionMarket Neutral Pair - vinanet.vn
Drugs Made In America Acquisition Corp. (DMAA) Stock Price, Chart, News & Analysis - Securities.io
Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingProfitability Factor - careplusvn.com
Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionPCR Divergence - careplusvn.com
DMII Holds at $10.13: Drugs Made In America Acquisition II Corp. Trades Flat Amid SPAC Market ConsolidationAdvance Decline Volume - dars.gov.et
Drugs Made In America Acquisition II (DMII) Earnings Date and Reports 2026 - MarketBeat
DMII Holds Steady at $10.13 as Acquisition Vehicle Trades in Tight RangeGamma Exposure - vinanet.vn
Drugs Made In America Acquisition Corp. (DMAA) logs $3.7M income as redemptions cut SPAC trust - Stock Titan
Drugs Made In America II (DMII) earns $8.7M but warns on going concern - Stock Titan
Drugs Made In America Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Karpus Management (DMAA) discloses 10.33% beneficial stake in SPAC - Stock Titan
Drugs Made In America (DMAA): First Trust funds disclose 3.24% beneficial stake - Stock Titan
DMAA Holds at $10.69 as SPAC Awaits Definitive Acquisition TargetPCR Moving Average - vinanet.vn
Drugs Made In America Acquisition II Corp. (DMIIU) Holds Steady at $10.17 as SPAC Unit Trades in Tight RangeIchimoku Cloud - vinanet.vn
Drugs Made In America Acquisition II Corp. (DMIIU) Holds Steady at $10.17 as SPAC Unit Trades in Tight RangeUp Down Ratio - dars.gov.et
Glazer Capital (DMAA) discloses 4.12% beneficial stake in Drugs Made in America - Stock Titan
Mizuho Financial Group (DMAA) discloses 8.5% beneficial stake in SPAC - Stock Titan
DMAAR Rights Hold Flat at $0.15 as Range-Bound Trading PersistsDouble Top - Vinanet
DMAAR Rights Hold Flat at $0.15 as Range-Bound Trading PersistsIV Percentile - careplusvn.com
DMII Holds at $10.11: Drugs Made In America Acquisition II Shows Typical Pre-Deal StabilitySystematic Flow - Vinanet
Drugs Made In America Acquisition Corp (DMAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Stock News Today - TradingKey
Drugs Made In America Acquisition Corp. Revenue Breakdown – BOATS:DMAAU - TradingView
Drugs Made In America Acquisition Corp. Revenue Breakdown – BOATS:DMAAR - TradingView
AstraZeneca falls to third-largest UK company amid US merger talks - theguardian.com
DMAAR Rights Edge Up to $0.16 as Tight Range Between Support and Resistance PersistsVolume Oscillator - Vinanet
Drugs Made In America Acquisition Corp. Revenue Breakdown – NASDAQ:DMAAU - TradingView
PHAR Q2 2026 Earnings: Marginal EPS Miss Triggers 15.5% SelloffCFO Commentary Report - careplusvn.com
DMII Holds Steady at $10.12 as SPAC Trades Near Trust ValueDealer Positioning - vinanet.vn
DMAA Holds Steady at $10.71 as SPAC Continues Trading in Tight RangeSynthetic Short - vinanet.vn
DMAA Holds Steady at $10.71 as SPAC Continues Trading in Tight RangeSentiment Shift - careplusvn.com
Law firm launches legal inquiries into mergers of LXP, DMAA, PSNL, and FNWD for shareholder protection. - Pluang
Drugs Made In America Acquisition II Ord Shs (DMII) Cash Flow - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMIIR - TradingView
0.21%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):